← Back to the feed

Gabon seeks protections as global interest grows in ibogaine treatment

The Guardian ·

Iboga root bark is used in several Gabonese Bwiti traditions, where practitioners say it is part of a wider spiritual and healing practice. Growing international interest in ibogaine, a drug made from the plant, could bring a surge in demand and raise questions about protecting Gabon’s cultural knowledge and forest resources.

Early studies have reported possible benefits for addiction and mental health, but the evidence remains limited. A 2024 study of 30 US veterans found large average reductions in PTSD, depression and anxiety scores after ibogaine and magnesium, but it was small, uncontrolled and included other therapies. Texas has committed $50m to a trial, while a US executive order has directed agencies to create a treatment pathway; a clinic in Cancún lists programmes costing $13,500 to $19,500.

  • Gabonese traditions use iboga as part of broader Bwiti practices.
  • US interest in ibogaine could increase demand for the plant.
  • Early research is promising but not conclusive.

Americas Business Health Medicine World

Read the full article at the source →

Originally published by The Guardian as “The next ayahuasca? Gabon fights to protect sacred plant from US drug companies”.